• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Confronting the Delta Variant of SARS-CoV-2, Summer 2021.

作者信息

Del Rio Carlos, Malani Preeti N, Omer Saad B

机构信息

Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.

Hubert Department of Global Health, Rollins School of Public Health of Emory University, Atlanta, Georgia.

出版信息

JAMA. 2021 Sep 21;326(11):1001-1002. doi: 10.1001/jama.2021.14811.

DOI:10.1001/jama.2021.14811
PMID:34406361
Abstract
摘要

相似文献

1
Confronting the Delta Variant of SARS-CoV-2, Summer 2021.应对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的德尔塔变异株，2021年夏季
JAMA. 2021 Sep 21;326(11):1001-1002. doi: 10.1001/jama.2021.14811.
2
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response.利妥昔单抗治疗患者的新型冠状病毒2型疫苗接种：体液免疫受损但细胞免疫反应可诱导的证据
Ann Rheum Dis. 2021 Oct;80(10):1355-1356. doi: 10.1136/annrheumdis-2021-220408. Epub 2021 May 6.
3
SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.接种疫苗6个月后，针对新冠病毒变异株的抗体水平下降。
JAMA. 2021 Sep 14;326(10):901. doi: 10.1001/jama.2021.15115.
4
Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'.关于“利妥昔单抗治疗患者的新型冠状病毒2疫苗接种：体液免疫受损但细胞免疫可诱导的证据”的通信
Ann Rheum Dis. 2021 Oct;80(10):e162. doi: 10.1136/annrheumdis-2021-220756. Epub 2021 Jul 16.
5
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases.利妥昔单抗而非其他抗风湿疗法，与风湿性疾病患者对SARS-CoV-2疫苗的血清学反应受损有关。
Ann Rheum Dis. 2021 Oct;80(10):1357-1359. doi: 10.1136/annrheumdis-2021-220604. Epub 2021 May 11.
6
Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report.自身免疫性疾病患者暂停免疫抑制治疗可改善对SARS-CoV-2疫苗的免疫反应：一例报告
Ann Rheum Dis. 2021 Oct;80(10):1359-1361. doi: 10.1136/annrheumdis-2021-220993. Epub 2021 Jul 16.
7
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.通过更换疫苗提高实体器官移植受者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫原性。
Clin Microbiol Infect. 2021 Oct;27(10):1529-1530. doi: 10.1016/j.cmi.2021.06.022. Epub 2021 Jun 27.
8
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.一名类风湿性关节炎患者接种BNT162b2加强针成功，且最初抗体反应呈阴性。
Ann Rheum Dis. 2021 Oct;80(10):1361-1362. doi: 10.1136/annrheumdis-2021-220834. Epub 2021 Jun 24.
9
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.异源ChAdOx1 nCoV-19疫苗和mRNA-1273疫苗接种
N Engl J Med. 2021 Sep 9;385(11):1049-1051. doi: 10.1056/NEJMc2110716. Epub 2021 Jul 14.
10
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort.在一项单中心队列研究中，慢性炎症性疾病和免疫抑制治疗患者的抗 SARS-CoV-2 mRNA 疫苗的免疫原性和安全性。
Ann Rheum Dis. 2021 Oct;80(10):1306-1311. doi: 10.1136/annrheumdis-2021-220272. Epub 2021 Mar 24.

引用本文的文献

1
Willingness among adults in the United States to receive a combination influenza and COVID-19 vaccine.美国成年人接种流感和新冠病毒联合疫苗的意愿。
Hum Vaccin Immunother. 2025 Dec;21(1):2532272. doi: 10.1080/21645515.2025.2532272. Epub 2025 Jul 11.
2
Wastewater-Based Surveillance of Respiratory Syncytial Virus Reveals a Temporal Disconnect in Disease Trajectory across an Active International Land Border.基于废水的呼吸道合胞病毒监测揭示了活跃的国际陆地边界沿线疾病轨迹的时间脱节。
Environ Health (Wash). 2025 Jan 29;3(4):425-435. doi: 10.1021/envhealth.4c00168. eCollection 2025 Apr 18.
3
The Behaviour of IL-6 and Its Soluble Receptor Complex during Different Waves of the COVID-19 Pandemic.
新冠疫情不同阶段白细胞介素-6及其可溶性受体复合物的行为
Life (Basel). 2024 Jun 27;14(7):814. doi: 10.3390/life14070814.
4
SARS-CoV-2 Delta variant remains viable in environmental biofilms found in meat packaging plants.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）德尔塔变异株在肉类包装厂发现的环境生物膜中仍具有活性。
PLoS One. 2024 Jun 13;19(6):e0304504. doi: 10.1371/journal.pone.0304504. eCollection 2024.
5
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development.我们在新冠疫情时代过去四年充满挑战的岁月中学到的经验教训：药物治疗、新冠长期并发症和疫苗研发。
Virol J. 2024 Apr 26;21(1):98. doi: 10.1186/s12985-024-02370-6.
6
Temporal assessment of SARS-CoV-2 detection in wastewater and its epidemiological implications in COVID-19 case dynamics.新冠病毒在废水中检测的时间评估及其对新冠肺炎病例动态的流行病学影响
Heliyon. 2024 Apr 9;10(8):e29462. doi: 10.1016/j.heliyon.2024.e29462. eCollection 2024 Apr 30.
7
Regional variations in vaccination against COVID-19 in Germany.德国 COVID-19 疫苗接种的地区差异。
PLoS One. 2024 Apr 18;19(4):e0296976. doi: 10.1371/journal.pone.0296976. eCollection 2024.
8
Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy adjustments.中国 COVID-19 应对和管理策略的轨迹：基于科学依据的策略调整。
Front Med. 2024 Feb;18(1):19-30. doi: 10.1007/s11684-024-1074-6. Epub 2024 Apr 2.
9
Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence.奥密克戎和德尔塔变异株的比较：当前证据的系统评价。
Infect Disord Drug Targets. 2024;24(7):e050324227686. doi: 10.2174/0118715265279242240216114548.
10
Impact of implemented vaccination strategies on vaccine uptake and attitude of final year pharmacy students toward COVID-19 vaccines in Gezira State, Sudan.苏丹杰济拉州实施的疫苗接种策略对最后一年药学专业学生的疫苗接种率及对新冠疫苗态度的影响
Vaccine X. 2023 Nov 28;15:100416. doi: 10.1016/j.jvacx.2023.100416. eCollection 2023 Dec.